✦ LIBER ✦

Effectiveness of oral iron chelators assayed in the rat

✍ Scribed by Byoung-Kook Kim; Helmut A. Huebers; Clement A. Finch

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 551 KB
Volume: 24
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830240307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deferiprone, an oral iron chelator, amel

Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats

✍ Jacob Ablin; Oded Shalev; Elimelech Okon; Fanny Karmeli; Dr. Daniel Rachmilewitz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

lron is pivotal in producing tissue-damaging reactive oxygen metabolites. Our aim is to determine the antiinflammatory activity of deferiprone, an oral iron chelator, in experimental colitis and gastritis. Colitis was induced by intraceccal administration of 2 ml 5% acetic acid or by intracolonic ad

Effect of an oral iron chelator or iron-

Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda

✍ Nadia Gorman; Adrian Zaharia; Heidi S. Trask; Juliana G. Szakacs; Nicholas J. Ja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Porphyria cutanea tarda is a liver disease characterized by elevated hepatic iron and excessive production of uroporphyrin (URO). Phlebotomy is an effective treatment that probably acts by reducing hepatic iron. Here we used Hfe(-/-) mice to compare the effects on hepatic URO accumulation of two dif

Effect of iron salts, haemosiderins, and

Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay

✍ D. Anderson; A. Yardley-Jones; C. Vives-Bauza; W. Chua-anusorn; C. Cole; J. Webb 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Effect of iron chelators on proliferatio

Effect of iron chelators on proliferation and iron uptake in hepatoma cells

✍ Anthony Kicic; Anita C. G. Chua; Erica Baker 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## BACKGROUND. The siderophore desferrioxamine mesylate (DFO) is used routinely in clinical practice to treat diseases of iron (Fe) overload. Recent studies suggest that DFO and other chelators may have potential in the treatment of cancer. The current study reports the findings obtained when a nu

Effects of oral epigallocatechin gallate

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats

✍ Joong-Hwa Chung; Dong-Hyun Choi; Jun-Shik Choi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

Effect of the iron chelator desferrioxam

Effect of the iron chelator desferrioxamine on manganese-induced toxicity of rat pheochromocytoma (PC12) cells

✍ Jerome A. Roth; Li Feng; Kevin G. Dolan; Agnieszka Lis; Michael D. Garrick 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

## Abstract Alterations in iron levels are likely to influence the biological actions of Mn in PC12 cells, because both metals are transported via the divalent metal transporter 1 (DMT1; also Nramp2 or DCT1). Studies were performed to determine the effect of the iron chelator desferrioxamine (DfO)